Faeth Therapeutics Trades Down 1.06% in Latest 24‑Hour Period
Faeth Therapeutics (FTH) closed its most recent trading session down 1.06 % at 06:51 AM Central Europe on Friday, 23 October 2026. The stock is currently listed at approximately USD 20.10 on major exchanges.
Key Market Metrics
- Current Share Price: USD 20.10
- Shares Outstanding: 25.8 million
- Market Capitalisation: USD 531.5 million
- Volume Traded (last 24 h): USD 3.8 million worth of shares
- 24‑Hour Percentage Change: –1.06 %
- Monthly Performance: –38.41 % since the previous month‑end
- 200‑Day Simple Moving Average: USD 24.89
- 52‑Week High: USD 42.14 (recorded 08 September 2026)
- 52‑Week Low: USD 7.45 (recorded 05 December 2025)
Recent Performance of Peer Companies
| Ticker | 24‑Hour Change | Current Price | Market Cap (USD M) |
|---|---|---|---|
| FOXF | +3.23 % | 15.33 | 624.2 |
| RZAI | +8.37 % | 11.31 | 619.3 |
| GYRE | –0.68 % | 5.86 | 625.6 |
| KIDS | +3.65 % | 24.71 | 622.5 |
| CLYM | +0.65 % | 10.54 | 624.3 |
Company Overview
Faeth Therapeutics is a clinical‑stage immunotherapy company operating within the healthcare sector. Its primary focus is on discovering and developing next‑generation therapies, with particular emphasis on cancer treatment.
This article provides a concise snapshot of Faeth Therapeutics’ recent trading activity and key financial metrics, positioned alongside the performance of comparable companies in the sector.
